Wednesday, May 13, 2015
Pfizer breast cancer drug shines in latest trial
Pfizer's newly approved breast cancer treatment Ibrance has improved survival … receptor 2 negative (HER2-) metastatic breast cancer following disease progression during or … receptor 2 negative (ER+/HER2-) breast cancer.
The drug was fast-tracked through …
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment